Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 90,651–90,662 of 90,662 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00051675	Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas	completed	Phase 1	30	XOMA (US) LLCINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00051779	An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer	completed	Phase 1	—	Chugai Pharma USAINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00052130